Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Pharmacology|March 3, 2020
Desmetramadol Is Identified as a G-Protein Biased µ Opioid Receptor AgonistJohn A Zebala, Aaron D Schuler, Stuart J Kahn, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2006
Bivalent inhibitors of glutathione S-transferase: the effect of spacer length on isozyme selectivityDean Y Maeda, Sumit S Mahajan, William M Atkins, et al.
Nucleic Acids Research|May 2, 2008
Snap-to-it probes: chelate-constrained nucleobase oligomers with enhanced binding specificityJoel R Morgan, Robert P Lyon, Dean Y Maeda, et al.
Molecular Pharmaceutics|April 19, 2005
Increased acyclovir oral bioavailability via a bile acid conjugateSanna Tolle-Sander, Kimberley A Lentz, Dean Y Maeda, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 26, 2009
Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanismDean Y Maeda, Mark T Quinn, Igor A Schepetkin, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
N-arylalkylpiperidines as high-affinity sigma-1 and sigma-2 receptor ligands: phenylpropylamines as potential leads for selective sigma-2 agentsDean Y Maeda, Wanda Williams, Wes E Kim, et al.
Cancers|May 16, 2023
Regression and Eradication of Triple-Negative Breast Carcinoma in 4T1 Mouse Model by Combination ImmunotherapiesSaifun Nahar, Yue Huang, Bethany A Nagy, et al.
Cancers|March 6, 2021
Vaccine Increases the Diversity and Activation of Intratumoral T Cells in the Context of Combination ImmunotherapyLucas A Horn, Kristen Fousek, Duane H Hamilton, et al.
The Journal of Pain|April 22, 2019
Desmetramadol Has the Safety and Analgesic Profile of Tramadol Without Its Metabolic Liabilities: Consecutive Randomized, Double-Blind, Placebo- and Active Comparator-Controlled TrialsJohn A Zebala, Shawn L Searle, Lynn R Webster, et al.
Journal of Medicinal Chemistry|September 26, 2014
Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2Dean Y Maeda, Angela M Peck, Aaron D Schuler, et al.
Pageof 3